Name (Synonyms) | Correlation | |
---|---|---|
drug199 | CHLORPROMAZINE (CPZ) Wiki | 0.50 |
drug822 | Pandemic control measures Wiki | 0.50 |
drug795 | Online survey Wiki | 0.50 |
drug925 | Questionnaire to study the psychological impact of confinement Wiki | 0.50 |
drug91 | Assessment of postnatal depression using the the Edinburgh questionnaire between 4 and 6 weeks after delivery Wiki | 0.50 |
drug1064 | Standard of Care (SOC) Wiki | 0.35 |
Name (Synonyms) | Correlation | |
---|---|---|
D003866 | Depressive Disorder NIH | 1.00 |
D003863 | Depression, NIH | 0.55 |
D019964 | Mood Disorders NIH | 0.50 |
D019052 | Depression, Postpartum NIH | 0.35 |
D001008 | Anxiety Disorders NIH | 0.17 |
Name (Synonyms) | Correlation |
---|
There are 4 clinical trials
Postnatal depression is an important problematic in French population with approximatively 10 -20% of women who suffer from postnatal depression. This pathology may have strong negative impact on both women and neonate's health. The women's satisfaction degree in front of childbirth is an important factor associated with postnatal depression since women unsatisfied of their childbirth and/or women with a complicated childbirth are more encline to suffer from postnatal depression. It is likely that the actual context of Covid 19 pandemia and the change in obstetrical cares organization may have a negative impact on women's satisfaction about their childbirth and so a negative impact on the risk of postnatal depression.
Description: proportion of women with an Edinburgh score higher than 12 between 4 and 6 weeks postpartum
Measure: Report postnatal depression between 4 of 6 weeks during the covid 19 pandemia Time: 4-6 weeks postpartumDescription: Existence of an association with postnatal depression and these factors: socio demographic women's characteristics, modalities of pregnancy management, satisfaction and experience about delivery, postnatal pelvic floor disorders, self rated health for the woman and the child, modalities of delivery, prenatal anxiety
Measure: Report factors associated with postnatal depression between 4 of 6 weeks during the covid 19 pandemia Time: 4-6 weeks postpartumDescription: Scale from 0 to 10 of satisfaction ; answers to the WOMBLSQ4 questionnaire about childbirth experience and satisfaction
Measure: Describe the experience and the satisfaction about delivery during the covid 19 pandemia Time: within the week after deliveryQuarantine is an unpleasant experience : separation from loved ones, loss of freedom, uncertainty about infection status, boredom .It may lead to negative mental health consequences and thus the emergence of anxiety and depressive symptoms. Poor social contacts and history of psychiatric disorders are factors increasing the negative psychological impact of confinement. Patients with psychiatric disorders are therefore particularly vulnerable during quarantine. Only one study has reported that history of psychiatric disorder was associated with a higher risk of anxiety and anger at 4 - 6 months after the end of quarantine. Since March 17th, 2020 the French government has implemented national containment measures due to the Covid-19 epidemic. This situation has led to a reorganization of care as requested on March 22nd, 2020 in the recommendations applicable to the organization of care in psychiatric services: priority to telephone contacts and teleconsultations by multiplying contacts and assessments. As part of the telephone contacts that are now part of the recommended care, patients are systematically interviewed on the impact of the confinement situation on their psychological well-being with self-questionnaires used in the daily clinical practice. Assessing the negative psychological impact in patients with a psychiatric history is essential to better deploy post-confinement management. This assessment will provide preliminary indicators for the appropriate organization of care.
Description: depressive symptomatology with Patient Health Questionnaire (PHQ-9 scale )
Measure: Depressive Symptomatology Time: during confinementDescription: depressive symptomatology with Patient Health Questionnaire (PHQ-9 scale )
Measure: Depressive Symptomatology Time: post-confinement : 15 days, 3 months, 6 monthsDescription: likert scale
Measure: Psychological pain Time: confinementDescription: quality of sleep assessed with Insomnia Seveity Index (ISI scale)
Measure: sleep Time: confinementDescription: quality of sleep assessed with Insomnia Seveity Index (ISI scale)
Measure: sleep Time: post-confinement (15 days, 3 months, 6 months)Description: anxiety intensity assessed by Generalized Anxieety Disorder (GAD-7)
Measure: anxiety Time: confinementDescription: anxiety intensity assessed by Generalized Anxieety Disorder (GAD-7)
Measure: anxiety Time: post-confinement (15 days, 3 months, 6 months)Description: likert scale
Measure: psychological pain Time: post-confinement (15 days, 3 months, 6 months)Description: likert scale
Measure: physical pain Time: confinementDescription: likert scale
Measure: physical pain Time: post-confinement (15 days, 3 months, 6 months)Description: staxi state scale
Measure: anger Time: confinementDescription: staxi state scale
Measure: anger Time: post-confinement (15 days, 3 months, 6 months)Description: Assessed by the Stressful Event Impact Scale - Horowitz
Measure: Stressful Event Impact Time: confinementDescription: Assessed by the Stressful Event Impact Scale - Horowitz
Measure: Stressful Event Impact Time: post-confinement (15 days, 3 months, 6 months)Description: declarative psychotropic drugs consumption
Measure: Use of psychotropic drugs Time: confinementDescription: declarative psychotropic drugs consumption
Measure: Use of psychotropic drugs Time: post-confinement (15 days, 3 months, 6 months)Description: declarative consumption
Measure: Tobacco consumption Time: confinementDescription: declarative consumption
Measure: Tobacco consumption Time: post-confinement (15 days, 3 months, 6 months)Description: declarative consumption
Measure: alcohol consumption Time: post-confinement (15 days, 3 months, 6 months)Description: declarative consumption
Measure: alcohol consumption Time: confinementDescription: declarative consumption
Measure: Illicit substances consumption Time: confinementDescription: declarative consumption
Measure: Illicit substances consumption Time: post-confinement (15 days, 3 months, 6 months)Description: LOT-R questionnaire
Measure: orientation of life Time: confinementDescription: LOT-R questionnaire
Measure: orientation of life Time: post-confinement (15 days, 3 months, 6 months)The article presents a protocol of a cross-sectional study of mental health of pregnant women in relation to the COVID 19 pandemic. The primary aim is to compare differences in anxiety and depression scores of pregnant women between countries affected by the COVID-19 pandemic. The secondary aim is to assess demographic, economic, and social aspects affecting maternal anxiety and depression scores among pregnant women worldwide in the time of the COVID-19 pandemic. Finally, investigators will be able to compare differences in perception of the different aspects of the COVID-19 pandemic (social distancing, restrictions related to delivery) between countries and according to the epidemic status (number of infected patients, number of reported deaths). The comparisons will also be done according to COVID-19 status of the participants.
Description: Anxiety measured by General Anxiety Disorder-7 (GAD-7) scale. Scoring:5-9 mild; 10-14 moderate; >15 severe. Minimum 0, maximum 21 points
Measure: Anxiety Time: 4 monthsDescription: Depression measured by Patient Health Questionnaire-9 (PHQ-9) scale. Scoring: 5-9 mild;10-14 moderate; 15-19 moderately severe; >20 severe. Minimum 0 maximum 27 points
Measure: Depression Time: 4 monthsIt is aimed to investigate the depression and quality of life of Turkish society caused by Covid-19 pandemic and reveal the relationship between them
Description: Participants are asked to give information about: age, gender, educational status, height, weight, occupation, working status, city inhabited, whether they live alone or with someone, whether they have a chronic disease, have a pet, do physical activity, eat healthy and sufficient, have qualified sleep, whether they are supported economically.
Measure: Sociodemographic information form Time: two months after Covid 19 recognised as pandemicDescription: Zung depression scale, developed by Zung (Zung, 1965), is patient rating depression scale, was used to asses four domains related to depression; somatic, mood disorders, psychomotor and psychological disorders. Each question is rated on a 4-point Likert scale (0- never, 1- sometimes, 2- frequently, 3- always). Scale contains 10 straight 10 reverse questions. The total score is calculated from the raw score obtained (total score = (raw score / 80) * 100). Accordingly, scores less than 50 are normal or no psychopathology; between 50 and 59 points indicates mild level, between 60 and 69 points indicate moderate level and 70 and above points indicate severe level depression (Thurber et al., 2002). The validity reliability of the scale was studied on Turkish society (Gencdogan & Nihal, 2011)
Measure: Zung Depression Scale Time: two months after Covid 19 recognised as pandemicDescription: World Health Organization Quality of Life Bref is the short version of the WHOQOL-100 to assess the health-related quality of life (Harper et al., 1998), which has efficient psychometric properties, valid and reliable for Turkish society (Eser et al., 1999). It is essential for epidemiological survey and international report has built for psychometric properties for 26 country where Turkey within (Skevington et al., 2004). It has 4 domains; physical health, psychology, social relations and environment. Each question is answered on a 5-point Likert scale. The raw score is converted into a percentage system. The quality of life is interpreted as good as it gets closer to 100% (Akvardar et al., 2006).
Measure: World Health Organization Quality of Life - Bref Time: two months after Covid 19 recognised as pandemic